Literature DB >> 13442910

Nuclear structure in cancer tissues.

M M BLACK, F D SPEER.   

Abstract

Entities:  

Keywords:  NEOPLASMS/pathology

Mesh：

Year:  1957        PMID： 13442910

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN： 0039-6087


× No keyword cloud information.
  60 in total

1.  Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.

Authors:  Naoki Niikura; Jun Liu; Colleen M Costelloe; Shana L Palla; John E Madewell; Naoki Hayashi; Tse-Kuan Yu; Yutaka Tokuda; Richard L Theriault; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Oncologist       Date:  2011-05-31

2.  Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.

Authors:  Naoki Niikura; Jun Liu; Naoki Hayashi; Shana L Palla; Yutaka Tokuda; Gabriel N Hortobagyi; Naoto T Ueno; Richard L Theriault
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

3.  Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.

Authors:  Kanwal P S Raghav; Leonel F Hernandez-Aya; Xiudong Lei; Marianan Chavez-Macgregor; Funda Meric-Bernstam; Thomas A Buchholz; Aysegul Sahin; Kim-Anh Do; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

4.  Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.

Authors:  Soley Bayraktar; Ana M Gonzalez-Angulo; Xiudong Lei; Aman U Buzdar; Vicente Valero; Amal Melhem-Bertrandt; Henry M Kuerer; Gabriel N Hortobagyi; Aysegul A Sahin; Funda Meric-Bernstam
Journal:  Cancer       Date:  2011-09-27       Impact factor: 6.860

5.  Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.

Authors:  Soley Bayraktar; Angelica M Gutierrez-Barrera; Diane Liu; Tunc Tasbas; Ugur Akar; Jennifer K Litton; E Lin; Constance T Albarracin; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Banu K Arun
Journal:  Breast Cancer Res Treat       Date:  2011-08-10       Impact factor: 4.872

6.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

7.  Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Hee Jung Kim; Chan-il Park; Byeong Woo Park; Hy-de Lee; Woo Hee Jung
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

8.  Heterogeneity of invasive ductal carcinoma: proposal for a hypothetical classification.

Authors:  Baik-Hyeon Jo; Yi-Kyeong Chun
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

9.  Significance of nuclear morphometry in cytological aspirates of breast masses.

Authors:  Shivani Kalhan; Suparna Dubey; Sonia Sharma; Sharmila Dudani; Monika Dixit
Journal:  J Cytol       Date:  2010-01       Impact factor: 1.000

10.  Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.

Authors:  Shaheenah Dawood; Kristine Broglio; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.